Southern African Development Community #phrma

Posted On Apr 23 2017 by

#pharmaceutical business plan # Use of appropriate pharmaceuticals is central to disease treatment and prevention. However, access to affordable, safe, and quality-assured medicines is uneven in Southern Africa. A lack of standardised legislation for pharmaceutical usage and disparate treatments for diseases currently affect healthcare in the region, creating challenges for workers already under pressure. These issues contributed to the creation of the Southern African Development Community (SADC) Pharmaceutical Programme in June 2004, now located within the Social and Human Development and Special Programmes Directorate. The SADC Pharmaceutical Programme The programme aims to enhance the capacities of Member States to prevent …


Alkermes Contract Pharma Services – Your Outsourcing Partner of Choice for Pharmaceutical Product Development and Manufacturing – Pharmaceutical Technology #watson #pharma

Posted On Apr 22 2017 by

#contract pharma # Alkermes Contract Pharma Services – Your Outsourcing Partner of Choice for Pharmaceutical Product Development and Manufacturing As part of Alkermes plc, Alkermes Contract Pharma Services provides solid oral dosage product development, scale-up and manufacturing services and sterile fill / finish capabilities to the global pharmaceutical market. With over 40 years in the service business, we have proven expertise in solid oral drug product development, process design / process improvement, tech transfer and commercial scale cGMP manufacturing as well as sterile fill finishing of injectable dosage forms. We have assisted our blue chip list of partners in the …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #d #pharma

Posted On Apr 21 2017 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Pharmaceutical Development Jobs #merk #pharma

Posted On Apr 15 2017 by

#pharmaceutical research jobs # Pharmaceutical Development Jobs Make a meaningful difference If you’re setting your sights on a career in Pharmaceutical Development, then you’ve already decided that you want to make a difference. There’s no better place to make that happen than at AstraZeneca. Help us find the answers to some of humankind’s biggest health problems. There is a real and urgent need for cutting-edge science and innovative treatment approaches. We’re looking for individuals who can apply their talents and make a difference to patients all over the world. Turning molecules into medicines In Pharmaceutical Development you can use your …


Research – Development News Channel #msd #pharma

Posted On Apr 14 2017 by

#latest pharmaceutical news # Research Development News Channel Antibody reduces harmful brain amyloid plaques in Alzheimer’s patients Although the causes of Alzheimer’s disease are still unknown, it is clear that the disease commences with progressive amyloid deposition in the brains of affected persons between ten and fifteen years before the emergence of initial clinical symptoms such as memory loss. Researchers have now been able to show that Aducanumab, a human monoclonal antibody, selectively binds brain amyloid plaques, thus enabling microglial cells to remove the plaques. Last Updated: Saturday, 03 September 2016 Caffeine and its analogues revert memory deficits by normalizing …


Pharma research and development outsourcing: PwC #pharma #industry #news

Posted On Apr 13 2017 by

#outsourcing pharma # R /* 728×90, создано 05.02.11 */ google_ad_slot = “6127977750”; google_ad_width = 670; google_ad_height = 90; //–>


The Pharmaceutical Industry: a key player in development #pharma #group

Posted On Apr 7 2017 by

#pharmaceutical market # In 1996 a meningococcal meningitis epidemic was declared in Kano’s State, Nigeria. Doctors Without Borders (Médecins sans Frontières) responded sending a team of volunteer physicians to the city of Kano, capital of the region and second largest city of Nigeria. They treated patients with chloamphenicol, one of the two antibiotics, as well as ceftriaxone, recommended by the World Health Organization (WHO) to treat meningococcal meningitis in areas that have limited health care resources of Africa. At the time of the epidemic, the US pharmaceutical Pfizer was trying to obtain the approval of the US Food and Drug …


Patheon Reaches Agreement With BSP Pharmaceuticals for Development and Manufacture of Cytotoxics #helvoet #pharma

Posted On Apr 7 2017 by

#bsp pharma # Patheon Reaches Agreement With BSP Pharmaceuticals for Development and Manufacture of Cytotoxics TORONTO, July 2 /PRNewswire/ — Patheon (TSX:PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry, has completed a shareholders agreement and a sales and marketing agreement with Italy’s BSP Pharmaceuticals, a company focussed on the development and manufacturing of cytotoxic pharmaceutical products. Under the terms of the sales and marketing agreement, Patheon will promote BSP’s cytotoxic manufacturing capacity and development services. Mr. Aldo Braca, President, Patheon Europe will be President and Chief Executive Officer of BSP Pharmaceuticals. Patheon is …


Innovative Medicines and Early Development – AstraZeneca Careers #pharma #marketing #jobs

Posted On Apr 7 2017 by

#pharmaceutical research jobs # Innovative Medicines and Early Development Jobs (IMED) IMED. A passion for science. Applications for the UK, US and Sweden 2015 IMED Graduate Programme are opening soon. The Innovative Medicines and Early Development Biotech Units are an exciting and vibrant place to work. Here we target areas that have the potential to revolutionise healthcare. With around 2,000 people, our dynamic and ambitious team is focused on success. Each year in excess of $1 billion is invested on discovering and developing the next generation of medicines, from initial target selection through to the end of Phase 2 clinical …


Alkermes Contract Pharma Services – Your Outsourcing Partner of Choice for Pharmaceutical Product Development and Manufacturing – Pharmaceutical Technology #esai #pharma

Posted On Apr 5 2017 by

#contract pharma # Alkermes Contract Pharma Services – Your Outsourcing Partner of Choice for Pharmaceutical Product Development and Manufacturing As part of Alkermes plc, Alkermes Contract Pharma Services provides solid oral dosage product development, scale-up and manufacturing services and sterile fill / finish capabilities to the global pharmaceutical market. With over 40 years in the service business, we have proven expertise in solid oral drug product development, process design / process improvement, tech transfer and commercial scale cGMP manufacturing as well as sterile fill finishing of injectable dosage forms. We have assisted our blue chip list of partners in the …